Somewhat Negative News Coverage Somewhat Unlikely to Impact Monsanto (MON) Stock Price

News coverage about Monsanto (NYSE:MON) has trended somewhat negative recently, according to Accern. The research group ranks the sentiment of press coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Monsanto earned a daily sentiment score of -0.04 on Accern’s scale. Accern also gave media headlines about the basic materials company an impact score of 42.9906538255253 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

These are some of the news stories that may have effected Accern Sentiment’s scoring:

A number of equities research analysts have recently weighed in on the company. Barclays reiterated an “equal weight” rating and issued a $124.00 price target (up from $120.00) on shares of Monsanto in a report on Thursday, October 5th. BMO Capital Markets reiterated a “buy” rating and issued a $128.00 price target on shares of Monsanto in a report on Thursday, October 5th. Macquarie downgraded Monsanto from an “outperform” rating to a “neutral” rating in a report on Wednesday, October 4th. Wells Fargo & Co boosted their price target on Monsanto from $107.50 to $118.00 and gave the company a “market perform” rating in a report on Tuesday, October 10th. Finally, Jefferies Group reiterated a “hold” rating and issued a $128.00 price target on shares of Monsanto in a report on Friday, September 15th. Eleven equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. Monsanto currently has a consensus rating of “Hold” and an average price target of $126.40.

Shares of Monsanto (NYSE MON) traded up $0.16 on Friday, reaching $119.70. The company had a trading volume of 2,200,000 shares, compared to its average volume of 3,090,000. The company has a market cap of $52,690.00, a P/E ratio of 22.13, a P/E/G ratio of 1.69 and a beta of 1.04. The company has a debt-to-equity ratio of 1.05, a quick ratio of 0.79 and a current ratio of 1.28. Monsanto has a 52-week low of $106.74 and a 52-week high of $122.79.

Monsanto (NYSE:MON) last issued its quarterly earnings data on Thursday, January 4th. The basic materials company reported $0.41 EPS for the quarter, missing the Zacks’ consensus estimate of $0.42 by ($0.01). The company had revenue of $2.66 billion for the quarter, compared to the consensus estimate of $2.77 billion. Monsanto had a return on equity of 40.13% and a net margin of 16.38%. Monsanto’s quarterly revenue was up .3% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.21 earnings per share. equities analysts predict that Monsanto will post 5.79 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 26th. Investors of record on Friday, January 5th will be paid a dividend of $0.54 per share. The ex-dividend date of this dividend is Thursday, January 4th. This represents a $2.16 dividend on an annualized basis and a yield of 1.80%. Monsanto’s payout ratio is currently 39.93%.

In related news, CFO Pierre Courduroux sold 4,320 shares of the company’s stock in a transaction on Thursday, October 19th. The stock was sold at an average price of $122.00, for a total transaction of $527,040.00. Following the completion of the transaction, the chief financial officer now directly owns 48,388 shares in the company, valued at approximately $5,903,336. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, VP Nicole M. Ringenberg sold 7,890 shares of the company’s stock in a transaction on Monday, October 16th. The stock was sold at an average price of $122.25, for a total value of $964,552.50. Following the transaction, the vice president now owns 38,600 shares of the company’s stock, valued at $4,718,850. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 20,310 shares of company stock valued at $2,458,328. 0.70% of the stock is owned by company insiders.

COPYRIGHT VIOLATION WARNING: “Somewhat Negative News Coverage Somewhat Unlikely to Impact Monsanto (MON) Stock Price” was reported by Stock Observer and is the sole property of of Stock Observer. If you are accessing this piece on another website, it was stolen and reposted in violation of U.S. and international copyright and trademark legislation. The original version of this piece can be viewed at https://www.thestockobserver.com/2018/01/12/somewhat-negative-news-coverage-somewhat-unlikely-to-impact-monsanto-mon-stock-price.html.

About Monsanto

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Insider Buying and Selling by Quarter for Monsanto (NYSE:MON)

Receive News & Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply